KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $6.3 billion.

  • Bristol Myers Squibb's Other Non-Current Assets rose 476.51% to $6.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 billion, marking a year-over-year increase of 476.51%. This contributed to the annual value of $6.1 billion for FY2024, which is 1368.72% up from last year.
  • As of Q3 2025, Bristol Myers Squibb's Other Non-Current Assets stood at $6.3 billion, which was up 476.51% from $5.9 billion recorded in Q2 2025.
  • Over the past 5 years, Bristol Myers Squibb's Other Non-Current Assets peaked at $7.4 billion during Q3 2021, and registered a low of $4.7 billion during Q2 2022.
  • Its 5-year average for Other Non-Current Assets is $5.7 billion, with a median of $5.9 billion in 2025.
  • As far as peak fluctuations go, Bristol Myers Squibb's Other Non-Current Assets plummeted by 3590.44% in 2022, and later surged by 2374.69% in 2024.
  • Bristol Myers Squibb's Other Non-Current Assets (Quarter) stood at $5.5 billion in 2021, then decreased by 10.75% to $4.9 billion in 2022, then increased by 8.7% to $5.4 billion in 2023, then grew by 13.69% to $6.1 billion in 2024, then increased by 3.72% to $6.3 billion in 2025.
  • Its Other Non-Current Assets stands at $6.3 billion for Q3 2025, versus $5.9 billion for Q2 2025 and $5.9 billion for Q1 2025.